Tesla’s stock may be headed for a significant increase, but it’s not a guaranteed ride. With over 125 hedge funds backing it, ...

Walmart CEO C. Douglas McMillon recently sold 29,124 shares of Walmart stock, amounting to approximately $2.7 million at an ...

UnitedHealth Group's stock dipped 1.3% after Robert W. Baird lowered their price target from $640 to $510. The stock traded ...

New Vernon Investment Management chopped its Exxon Mobil stake by nearly 92%, leaving just 1,600 shares and some spare change ...

Mastercard might not have the flash of a speculative moonshot, but its earnings game is pure gold. The company has grown ...

Rothschild Capital Partners dropped nearly half a million dollars into Home Depot stock, purchasing 1,250 shares like it was ...

Analysts lowered their price targets on Procter & Gamble, but the consensus still screams “buy.” Truist Financial cut its price target from $185 to $180, maintaining a “buy” rating. Others followed ...

Oxford Asset Management LLP gave Johnson & Johnson a healthy dose of confidence by raising its stake 257.8% in Q4, acquiring ...

Berkshire Hathaway’s upcoming earnings report has Wall Street less curious about profit and more about what Warren Buffett ...

Oracle Corp’s stock had a year that resembled a caffeine-fueled rollercoaster, with a peak of $198.31 and a trough of $113.65 ...

Analysts covering Costco have mostly chimed in with a confident "buy," though a cautious crew still says "hold." Out of 30 ...

AbbVie’s stock nudged up 0.7% after Guggenheim lifted its price target, joining a parade of bullish analyst upgrades. Several ...